Stock Research for AEMD

AEMD

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

AEMD Stock Chart & Research Data

The AEMD chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the AEMD chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


AEMD Due diligence Resources & Stock Charts

The AEMD stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View AEMD Detailed Price Forecast - CNN Money CNN View AEMD Detailed Summary - Google Finance
Yahoo View AEMD Detailed Summary - Yahoo! Finance Zacks View AEMD Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View AEMD Trends & Analysis - Trade-Ideas Barrons View AEMD Major Holders - Barrons
NASDAQ View AEMD Call Transcripts - NASDAQ Seeking View AEMD Breaking News & Analysis - Seeking Alpha
Spotlight View AEMD Annual Report - CompanySpotlight.com OTC Report View AEMD OTC Short Report - OTCShortReport.com
TradeKing View AEMD Fundamentals - TradeKing Charts View AEMD SEC Filings - Bar Chart
WSJ View Historical Prices for AEMD - The WSJ Morningstar View Performance/Total Return for AEMD - Morningstar
MarketWatch View the Analyst Estimates for AEMD - MarketWatch CNBC View the Earnings History for AEMD - CNBC
StockMarketWatch View the AEMD Earnings - StockMarketWatch MacroAxis View AEMD Buy or Sell Recommendations - MacroAxis
Bullish View the AEMD Bullish Patterns - American Bulls Short Pains View AEMD Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View AEMD Stock Mentions - StockTwits PennyStocks View AEMD Stock Mentions - PennyStockTweets
Twitter View AEMD Stock Mentions - Twitter Invest Hub View AEMD Investment Forum News - Investor Hub
Yahoo View AEMD Stock Mentions - Yahoo! Message Board Seeking Alpha View AEMD Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for AEMD - SECform4.com Insider Cow View Insider Transactions for AEMD - Insider Cow
CNBC View AEMD Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for AEMD - OTC Markets
Yahoo View Insider Transactions for AEMD - Yahoo! Finance NASDAQ View Institutional Holdings for AEMD - NASDAQ


Stock Charts

FinViz View AEMD Stock Insight & Charts - FinViz.com StockCharts View AEMD Investment Charts - StockCharts.com
BarChart View AEMD Stock Overview & Charts - BarChart Trading View View AEMD User Generated Charts - Trading View




Latest Financial News for AEMD


Aethlon Announces Appointment of Timothy Rodell as Interim Chief Executive Officer
Posted on Thursday December 13, 2018

SAN DIEGO, Dec. 13, 2018 /PRNewswire/ -- Aethlon Medical, Inc. (AEMD), a therapeutic technology company focused on unmet needs in global health, announced today the appointment of Timothy C. Rodell, M.D., FCCP, as Interim Chief Executive Officer, effective as of December 10, 2018.  Dr. Rodell joins Aethlon from GlobeImmune, Inc. where he was President, and Chief Executive Officer and a member of their board of directors prior to the shareholder majority acquisition of the company.  Dr. Rodell brings an impressive record of results in global, strategic and operational roles to Aethlon.  Dr. Rodell succeeds James Joyce, who will serve as a consultant to Aethlon during the transition.


Today’s Research Reports on Stocks to Watch: Arsanis and Aethlon Medical
Posted on Wednesday November 28, 2018

NEW YORK, NY / ACCESSWIRE / November 28, 2018 / Biotech stocks Arsanis and Aethlon Medical were both seeing big gains on Tuesday on positive developments. Arsanis and privately held X4 Pharmaceuticals have agreed to merge and Aethlon announced it had received Breakthrough Device designation from FDA for their Hemopurifier in the treatment of cancer.


AEMD: Breakthrough Device Designation Granted for Cancer Therapy. Could Be Game-Changer for AEMD
Posted on Tuesday November 27, 2018

By Brian Marckx, CFA NASDAQ:AEMD READ THE FULL AEMD RESEARCH REPORT Breakthrough Device Designation Granted for Cancer Therapy This morning Aethlon (NASDAQ:AEMD) announced that they received Breakthrough ...


The Reason Healthcare Stocks Are Being Called Home By Investors
Posted on Tuesday November 27, 2018

CORAL GABLES, FL / ACCESSWIRE / November 27, 2018 / Healthcare stocks helped boost the stock market rally on Monday. Recently concluded mid-term elections have provided a much-needed boost to the healthcare sector. New trends that the majority of healthcare companies are working on are also boosting the sector.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.